Fig. 5.

(a) Decrease in the chemotactic activity of neutrophils obtained from patients with Kawasaki disease (KD) following intravenous immunoglobulin (IVIG) therapy. *A significant decrease in chemotactic activity was noted in the neutrophils from patients with KD following IVIG therapy. Neutrophils from healthy volunteers were used as controls. Hanks' balanced salt solution (HBSS) was used as the FMLP (–) solution. FMLP (250 nm) in HBSS was used as the chemotactic solution, FMLP (+). Data are the average ± s.d. of triplicates. Representative data from one of 15 experiments are shown. (b). Chemotactic activity of monocytes from patients with KD. Monocytes from healthy volunteers were used as controls. HBSS was used as the FMLP (–) solution. FMLP (250 nm) in HBSS was used as the chemotactic solution, FMLP (+). Data are the average ± s.d. of triplicates. Representative data from one of 15 experiments are shown.